Off balance: Interferons in COVID-19 lung infections - eBioMedicine
What You Should Know about Peginterferon Alfa-2b for Adjuvant Treatment of Melanoma - The ASCO Post
Pharmaceuticals | Free Full-Text | Antiproliferative Properties of Type I and Type II Interferon | HTML
Frontiers | When Hepatitis B Virus Meets Interferons | Microbiology
Peginterferon and Ribavirin for Chronic Hepatitis C | NEJM
Targeting the interferon pathway with sifalimumab for the treatment of systemic lupus erythematosus | Immunotherapy
The interferon-alpha revival in CML | Semantic Scholar
Mechanism of action of ribavirin in the treatment of chronic hepatitis C. - Abstract - Europe PMC
Interferon alfa-2b triggers transforming growth factor-β1-induced apoptosis on preneoplastic liver | Annals of Hepatology
References in Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial - The Lancet
Human Interferon Alpha-2b: A Therapeutic Protein for Cancer Treatment
Frontiers | When Hepatitis B Virus Meets Interferons | Microbiology
Frontiers | Role of Type I and II Interferons in Colorectal Cancer and Melanoma | Immunology
Overview of Interferon: Characteristics, signaling and anti-cancer effect
Ribavirin mechanism of action. | Download Scientific Diagram
Frontiers | When Hepatitis B Virus Meets Interferons | Microbiology
Interferon-α in acute myeloid leukemia: an old drug revisited | Leukemia
INTERFERON THERAPY FOR CHRONIC HEPATITIS B and Combination Interferon + Lamivudine
Potential role of IFN-α in COVID-19 patients and its underlying treatment options | SpringerLink
Interferon - an overview | ScienceDirect Topics
Interferons α and β in cancer: therapeutic opportunities from new insights | Nature Reviews Drug Discovery
New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies - Journal of Hepatology
Frontiers | Role of Type I and II Interferons in Colorectal Cancer and Melanoma | Immunology
